34 studies found for:    "familial adenomatous polyposis"
Show Display Options
Rank Status Study
1 Completed Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
Conditions: Familial Adenomatous Polyposis;   Duodenal Neoplasms;   Duodenal Polyps
Interventions: Drug: Celecoxib;   Drug: Ursodeoxycholic acid;   Drug: Placebo
2 Active, not recruiting Multimedia Intervention in Patients With Familial Adenomatous Polyposis (FAP)
Conditions: Familial Adenomatous Polyposis;   Colorectal Cancer
Interventions: Behavioral: Web-Based Multimedia Intervention;   Behavioral: Questionnaire
3 Recruiting Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Eflornithine plus Sulindac;   Drug: Eflornithine and Placebo;   Drug: Sulindac and Placebo
4 Recruiting Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Calcumin (Curcumin);   Other: Risk Factor Questionnaire;   Other: Blood samples;   Other: Biopsies (Sigmoidoscopy);   Other: Biopsies (Upper endoscopy)
5 Withdrawn Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
Condition: Familial Adenomatous Polyposis
Intervention: Drug: curcumin
6 Completed Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Lyophilized Black Raspberries;   Drug: Placebo
7 Completed Chemoprevention Trial in Familial Adenomatous Polyposis Coli Using EPA
Conditions: Familial Adenomatous Polyposis Coli;   FAP
Interventions: Drug: Eicosapentanoic Acid (EPA);   Procedure: Endoscopy;   Procedure: Biopsies taken;   Procedure: Clinical Chemistry;   Procedure: Haematology;   Procedure: Physical examination;   Procedure: Vital signs;   Procedure: Urine pregnancy test;   Procedure: Completion of patient diary card;   Procedure: Peripheral blood sample
8 Terminated
Has Results
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Condition: Familial Adenomatous Polyposis (FAP)
Interventions: Drug: Celecoxib;   Other: Routine Medical Care
9 Recruiting Curcumin in Treating Patients With Familial Adenomatous Polyposis
Condition: Familial Adenomatous Polyposis
Interventions: Other: placebo;   Other: laboratory biomarker analysis;   Drug: curcumin
10 Withdrawn A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Condition: Familial Adenomatous Polyposis
Interventions: Drug: Eflornithine plus Sulindac;   Drug: Eflornithine plus Placebo;   Drug: Sulindac plus Placebo
11 Completed Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
Conditions: Colorectal Cancer;   Familial Adenomatous Polyposis
Interventions: Drug: celecoxib;   Other: placebo;   Drug: eflornithine;   Other: laboratory biomarker analysis;   Other: questionnaire administration
12 Recruiting Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Bevacizumab-IRDye800CW;   Device: Near infrared fluorescence endoscopy platform
13 Recruiting Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
Conditions: Colitis,Ulcerative;   Adenomatous Polyposis Coli;   Reservoir, Ileoanal
Intervention:
14 Recruiting The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
Condition: Familial Adenomatous Polyposis
Intervention: Drug: metformin
15 Recruiting A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Erlotinib;   Drug: Sulindac;   Drug: Placebo A;   Drug: Placebo B
16 Terminated Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Celecoxib;   Drug: Placebo
17 Unknown  Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Condition: Adenomatous Polyposis Coli
Interventions: Drug: Sulindac (drug);   Drug: VSL#3 (probiotic);   Drug: Inulin (probiotic)
18 Terminated A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP)
Condition: Adenomatous Polyposis Coli
Interventions: Drug: MK0966; rofecoxib / Duration of Treatment: 24 weeks;   Drug: Comparator: placebo / Duration of Treatment: 24 weeks
19 Unknown  Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
Condition: Adenomatous Polyposis Coli, Familial
Interventions: Drug: Ursodeoxycholic acid;   Drug: Placebo
20 Unknown  Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
Condition: Familial Adenomatous Polyposis
Intervention: Procedure: flexible sigmoidoscopy

Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results
Indicates status has not been verified in more than two years